BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38254675)

  • 1. Serum Brevican as a Biomarker of Cerebrovascular Disease in an Elderly Cognitively Impaired Cohort.
    Chia RSL; Minta K; Wu LY; Salai KHT; Chai YL; Hilal S; Venketasubramanian N; Chen CP; Chong JR; Lai MKP
    Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma osteopontin as a biomarker of Alzheimer's disease and vascular cognitive impairment.
    Chai YL; Chong JR; Raquib AR; Xu X; Hilal S; Venketasubramanian N; Tan BY; Kumar AP; Sethi G; Chen CP; Lai MKP
    Sci Rep; 2021 Feb; 11(1):4010. PubMed ID: 33597603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.
    Chai YL; Yeo HK; Wang J; Hilal S; Ikram MK; Venketasubramanian N; Wong BS; Chen CL
    J Alzheimers Dis; 2016; 51(4):1111-8. PubMed ID: 26923016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Placental Growth Factor as a Marker of Cerebrovascular Disease Burden in Alzheimer's Disease.
    Wu LY; Chong JR; Chong JPC; Hilal S; Venketasubramanian N; Tan BY; Richards AM; Chen CP; Lai MKP
    J Alzheimers Dis; 2024; 97(3):1289-1298. PubMed ID: 38217598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum IL-8 is a marker of white-matter hyperintensities in patients with Alzheimer's disease.
    Zhu Y; Chai YL; Hilal S; Ikram MK; Venketasubramanian N; Wong BS; Chen CP; Lai MK
    Alzheimers Dement (Amst); 2017; 7():41-47. PubMed ID: 28239640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed-Location Cerebral Microbleeds: An Imaging Biomarker for Cerebrovascular Pathology in Cognitive Impairment and Dementia in a Memory Clinic Population.
    Gyanwali B; Shaik MA; Venketasubramanian N; Chen C; Hilal S
    J Alzheimers Dis; 2019; 71(4):1309-1320. PubMed ID: 31524167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth differentiation factor-15 and white matter hyperintensities in cognitive impairment and dementia.
    Chai YL; Hilal S; Chong JPC; Ng YX; Liew OW; Xu X; Ikram MK; Venketasubramanian N; Richards AM; Lai MKP; Chen CP
    Medicine (Baltimore); 2016 Aug; 95(33):e4566. PubMed ID: 27537582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Hepatocyte Growth Factor Is Associated with Small Vessel Disease in Alzheimer's Dementia.
    Zhu Y; Hilal S; Chai YL; Ikram MK; Venketasubramanian N; Chen CP; Lai MKP
    Front Aging Neurosci; 2018; 10():8. PubMed ID: 29410622
    [No Abstract]   [Full Text] [Related]  

  • 9. Cerebrovascular disease in suspected non-Alzheimer's pathophysiology and cognitive decline over time.
    Saridin FN; Chew KA; Reilhac A; Gyanwali B; Villaraza SG; Tanaka T; Scheltens P; van der Flier WM; Chen CLH; Hilal S
    Eur J Neurol; 2022 Jul; 29(7):1922-1929. PubMed ID: 35340085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low plasma ergothioneine levels are associated with neurodegeneration and cerebrovascular disease in dementia.
    Wu LY; Cheah IK; Chong JR; Chai YL; Tan JY; Hilal S; Vrooman H; Chen CP; Halliwell B; Lai MKP
    Free Radic Biol Med; 2021 Dec; 177():201-211. PubMed ID: 34673145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brevican and Neurocan Peptides as Potential Cerebrospinal Fluid Biomarkers for Differentiation Between Vascular Dementia and Alzheimer's Disease.
    Minta K; Brinkmalm G; Portelius E; Johansson P; Svensson J; Kettunen P; Wallin A; Zetterberg H; Blennow K; Andreasson U
    J Alzheimers Dis; 2021; 79(2):729-741. PubMed ID: 33337373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma P-tau181 to Aβ42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant cerebrovascular disease.
    Chong JR; Ashton NJ; Karikari TK; Tanaka T; Saridin FN; Reilhac A; Robins EG; Nai YH; Vrooman H; Hilal S; Zetterberg H; Blennow K; Lai MKP; Chen CP
    Alzheimers Dement; 2021 Oct; 17(10):1649-1662. PubMed ID: 33792168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global cerebrovascular burden and long-term clinical outcomes in Asian elderly across the spectrum of cognitive impairment.
    Xu X; Chan YH; Chan QL; Gyanwali B; Hilal S; Tan BY; Ikram MK; Venketasubramanian N; Chen CL
    Int Psychogeriatr; 2018 Sep; 30(9):1355-1363. PubMed ID: 29665875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effects of Mean of Visit-to-Visit Blood Pressure on Incident Brain Vascular Lesions and Functional-Cognitive Decline.
    Gyanwali B; Cai CXT; Chen C; Vrooman H; Tan CS; Hilal S
    J Alzheimers Dis; 2021; 82(2):561-573. PubMed ID: 34057087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers of cardiac dysfunction in cognitive impairment and dementia.
    Hilal S; Chai YL; Ikram MK; Elangovan S; Yeow TB; Xin X; Chong JY; Venketasubramanian N; Richards AM; Chong JPC; Lai MKP; Chen C
    Medicine (Baltimore); 2015 Jan; 94(1):e297. PubMed ID: 25569645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer-Related Cerebrovascular Disease in Down Syndrome.
    Lao PJ; Gutierrez J; Keator D; Rizvi B; Banerjee A; Igwe KC; Laing KK; Sathishkumar M; Moni F; Andrews H; Krinsky-McHale S; Head E; Lee JH; Lai F; Yassa MA; Rosas HD; Silverman W; Lott IT; Schupf N; Brickman AM
    Ann Neurol; 2020 Dec; 88(6):1165-1177. PubMed ID: 32944999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Magnetic Resonance Imaging Markers of Cerebrovascular Disease Burden and Cognition.
    Xu X; Hilal S; Collinson SL; Chong EJ; Ikram MK; Venketasubramanian N; Chen CL
    Stroke; 2015 Oct; 46(10):2808-14. PubMed ID: 26330446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive effect of cerebral atrophy on cognition in dementia-free elderly with cerebrovascular disease.
    Xu X; Phua A; Collinson SL; Hilal S; Ikram MK; Wong TY; Cheng CY; Venketasubramanian N; Chen C
    Stroke Vasc Neurol; 2019 Sep; 4(3):135-140. PubMed ID: 31709119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White matter network damage mediates association between cerebrovascular disease and cognition.
    Hilal S; Liu S; Wong TY; Vrooman H; Cheng CY; Venketasubramanian N; Chen CL; Zhou JH
    J Cereb Blood Flow Metab; 2021 Aug; 41(8):1858-1872. PubMed ID: 33530830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts.
    Dadar M; Mahmoud S; Zhernovaia M; Camicioli R; Maranzano J; Duchesne S;
    Neuroimage Clin; 2022; 36():103204. PubMed ID: 36155321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.